Aptus Pharma Limited share price
BSE: APPL
Key numbers
- Market cap
- ₹ 595 Cr
- Current price
- ₹ 347.00
- 52-week high / low
- ₹ 366 / 32
- Stock P/E
- 111.9
- Book value
- ₹ 13.6
- Dividend yield
- 0.00%
- ROCE
- 29.7%
- ROE
- 30.5%
- Debt to equity
- 0.31
- Sales growth (3 yrs)
- 49.6%
- Profit growth (3 yrs)
- 189.7%
- 1-year return
- -
About Aptus Pharma Limited
Aptus Pharma Limited engages in the marketing and distribution of finished pharmaceutical formulations. The company operates through four divisions: Aptus Pharma, Pioneer division, which includes marketing of acute therapies including general anti-infectives, pain management, antacids, and gastrointestinal drugs; Aptus CD Care, Cardiac Diabetic division, which includes marketing of chronic therapies, including antihypertensive, anti-diabetic, and lipid-lowering; Aptus Wellcare offers wellness and nutraceutical products, over-the-counter (OTC) formulations, and personal care products; and Aptus Global, export division engages in exploring and developing opportunities in overseas markets, semi-regulated and emerging countries. It also offers anti-infectives, gastrointestinal, antacids, anti-allergic and respiratory, nutritional supplements, pain management, neuro-psychiatric, cardiovascular, antidiabetic, lipid-lowering, and general wellness products. In additio, the company develops and markets skin care, face care, hair care, personal hygiene, wellness, and self-care over-the-counter products. Its products are available in balms, capsules, drops, gels, injections, lotions,…
Quarterly results
Consolidated figures in ₹ crores
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Sales | 15 | 32 |
| Operating profit | 3 | 5 |
| Net profit | 2 | 3 |
| EPS (₹) | 1.05 | 1.68 |
Peers in Medical Distribution
Data for information only, not investment advice. Prices end of day.